- RESEARCH PROFESSOR | Psychiatry
- RESEARCH PROFESSOR (PENDING) | Neurology
- Alzheimer's Disease
- Hospital Affiliation
- The Mount Sinai Hospital
Neurology, American Board of Psychiatry and Neurology
Aging, Alzheimer's Disease, Brain, Endothelial Cells, Neuro-degeneration/protection, Stem Cells
Multi-Disciplinary Training Area
MD, Loyola University of Chicago
BA, University of Illinois
Residency, Internal Medicine
Edward Hines, Jr. VA Hospital
New York University Medical Center
Fellowship, Infectious Diseases
National Institute of Health
Research interests include Alzheimer's disease and related dementias, in particular how mutations in presenilin-1 cause familial Alzheimer's disease using transgenic mouse models. We also study the normal biological functions of the presenilin-1 gene using mouse models and cell culture.
Familial Alzheimer's disease
De Gasperi R, Gama Sosa MA, Wen PH, Li J, Curran T, Elder GA. Cortical Development in the Presenilin-1 Null Mutant Mouse Fails After Splitting of the Preplate and is Not Due to a Failure of Reelin-Dependent Signaling. Developmental Dynamics 2008; 237: 2405-2414.
De Gasperi R, Rocher AB, Gama Sosa MA, Wearne SL, Perez GM, Friedrich VL Jr, Hof PR, Elder GA. The IRG Mouse: A Two-Color Fluorescent Reporter for Assessing Cre-Mediated Recombination and Imaging Complex Cellular Relationships In Situ. Genesis 2008; 46: 308-317.
Elder GA, Ragnauth A, Dorr N, Franciosi S, Schmeidler J, Haroutunian V, Buxbaum JD. Increased locomotor activity in mice lacking the low-density lipoprotein receptor. Behavioral Brain Research 2008; 191: 256-265.
Gama Sosa MA, De Gasperi R, Rocher AB, Perez GM, Simons K, Cruz DE, Hof PR, Elder GA. Interactions of primary neuroepithelial progenitor and brain endothelial cells: distinct effect on neural progenitor maintenance and differentiation by soluble factors and direct contact. Cell Research 2007; 17: 619-626.
Elder GA, Cho J, English DF, Franciosi S, Schmeidler J, Gama Sosa MA, De Gasperi R, Fisher EA, Mathews PM, Haroutunian V, Buxbaum JD, . Elevated plasma cholesterol does not affect brain in mice lacking the low-density lipoprotein receptor. Journal of Neurochemistry 2007; 102: 1220-1231.
Franciosi S, De Gasperi R, Dickstein DL, English DF, Rocher AB, Janssen WM, Christoffel D, Gama Sosa MA, Hof PR, Buxbaum JD, Elder GA. Pepsin Pretreatment Allows Collagen IV Immunostaining of Blood Vessels in Adult Mouse Brain. Journal of Neuroscience Methods 2007; 163: 76-82.
Elder GA, De Gasperi R, Gama Sosa MA. Research Update: Neurogenesis in Adult Brain and Neuropsychiatric Disorders. The Mount Sinai Journal of Medicine 2006; 73: 931-940.
Wen PH, De Gasperi R, Gama Sosa MA, Rocher AB, Friedrich Jr. VL, Hof PR, Elder GA. Selective expression of presenilin-1 in neural progenitor cells rescues the cerebral hemorrhages and cortical lamination defects in presenilin-1 null mutant mice. Development 2005; 132: 3873-3883.
Wen PH, Hof PR, Chen X, Gluck K, Austin G, Younkin SG, Younkin LH, DeGasperi R, Gama Sosa MA, Robakis NK, Haroutunian V, Elder GA. The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice. Experimental Neurology 2004; 188: 224-237.
Gama Sosa MA, Wen PH, De Gasperi R, Perez G, Senturk E, Friedrich Jr. VL, Elder GA. Entorhinal Cortex Lesioning Promotes Neurogenesis in the Hippocampus of Adult Mice. Neuroscience 2004; 127: 881-891.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Elder did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.